Results 131 to 140 of about 29,991,050 (179)

CYFRA21-1 as a Tumor Marker in Patients with Malignant Head and Neck Tumor.

Practica Oto-Rhino-Laryngologica, 1996
OGAWA, Teruhiro, NISHIZAKI, Kazunori, AKAGI, Hirohumi, TSURUSAKO, Hirokazu, NISHIOKA, Keiko, ODA, Kazunari, KIMURA, Nobuhiko   +6 more
openaire   +2 more sources

High-Sensitivity Detection of the Lung Cancer Biomarker CYFRA21-1 in Serum Samples Using a Carboxyl-MoS₂ Functional Film for SPR-Based Immunosensors. [PDF]

Front Bioeng Biotechnol, 2020
Chiu NF, Yang HT.
europepmc   +1 more source

An Investigation of the Availability of CYFRA21-1 as a Tumor Marker in Head and Neck Cancer.

Practica Oto-Rhino-Laryngologica, 1997
Hideyuki KAWAUCHI, Shingo KAATAOKA, Keisuke SANO, Taiji KATOH, Jun-ichi IWAMOTO   +4 more
openaire   +2 more sources

Serum tumor marker CYFRA21-1 in patients with malignant pleural mesothelioma

Japan Journal of Molecular Tumor Marker Research, 2002
N., M., N., T., Y., H., Y., S., I., S., U., A., T., A., M., M., H., T.   +8 more
openaire   +1 more source

The combination assay of CYFRA21-1/ProGRP in Primary Lung Cancer.

Japan Journal of Molecular Tumor Marker Research, 1999
openaire   +1 more source

Effect of gefitinib on serum EGFR and CYFRA21-1 in patients with advanced non-small cell lung cancer. [PDF]

Oncol Lett, 2019
Ren H, Hu Y, Xie T, Jin C, Hu Y, Yang B.
europepmc   +1 more source

lk27 [PDF]

1, 1
core  

Differential analysis of lung adenocarcinoma and lung squamous cell carcinoma based on serum tumor markers: diagnostic performance and clinical utility. [PDF]

Clinics (Sao Paulo)
Chen Z, Chen L, Wu L, Zhang K.
europepmc   +1 more source